| Mediators of chronic pruritus in atopic dermatitis: getting the itch out? NK Mollanazar, PK Smith, G Yosipovitch Clinical reviews in allergy & immunology 51, 263-292, 2016 | 375 | 2016 |
| The genetics of chronic itch: gene expression in the skin of patients with atopic dermatitis and psoriasis with severe itch LA Nattkemper, HL Tey, R Valdes-Rodriguez, H Lee, NK Mollanazar, ... Journal of Investigative Dermatology 138 (6), 1311-1317, 2018 | 266 | 2018 |
| Psychological interventions in the treatment of chronic itch C Schut, NK Mollanazar, J Kupfer, U Gieler, G Yosipovitch Acta Derm Venereol 96 (2), 157-61, 2016 | 107 | 2016 |
| Practical approaches for diagnosis and management of prurigo nodularis: United States expert panel consensus S Elmariah, B Kim, T Berger, S Chisolm, SG Kwatra, N Mollanazar, ... Journal of the American Academy of Dermatology 84 (3), 747-760, 2021 | 101 | 2021 |
| Itch prevalence and characteristics in a Hispanic geriatric population: a comprehensive study using a standardized itch questionnaire R Valdes-Rodriguez, NK Mollanazar, J González-Muro, L Nattkemper, ... Acta dermato-venereologica 95 (4), 417-421, 2015 | 89 | 2015 |
| Chronic pruritus responding to dupilumab—a case series LL Zhai, KT Savage, CC Qiu, A Jin, R Valdes-Rodriguez, NK Mollanazar Medicines 6 (3), 72, 2019 | 75 | 2019 |
| Reduced itch associated with dupilumab treatment in 4 patients with prurigo nodularis NK Mollanazar, M Elgash, L Weaver, R Valdes-Rodriguez, S Hsu JAMA dermatology 155 (1), 121-122, 2019 | 68 | 2019 |
| Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials G Yosipovitch, N Mollanazar, S Ständer, SG Kwatra, BS Kim, E Laws, ... Nature medicine 29 (5), 1180-1190, 2023 | 52 | 2023 |
| Retrospective analysis of data from an itch center: Integrating validated tools in the electronic health record NK Mollanazar, M Sethi, RV Rodriguez, LA Nattkemper, FV Ramsey, ... Journal of the American Academy of Dermatology 75 (4), 842-844, 2016 | 42 | 2016 |
| Epidemiology of chronic pruritus: where have we been and where are we going? NK Mollanazar, SD Koch, G Yosipovitch Current Dermatology Reports 4, 20-29, 2015 | 37 | 2015 |
| Eosinophilic dermatosis of hematologic malignancy responding to dupilumab in a patient with chronic lymphocytic leukemia A Jin, BT Pousti, KT Savage, NK Mollanazar, JB Lee, S Hsu JAAD case reports 5 (9), 815-817, 2019 | 28 | 2019 |
| Psychological stress and skin symptoms in college students: results of a cross-sectional web-based questionnaire study C Schut, NK Mollanazar, M Sethi, LA Nattkemper, R Valdes-Rodriguez, ... Acta dermato-venereologica 96 (4), 550-551, 2016 | 27 | 2016 |
| Use of dupilumab in patients who are HIV‐positive: report of four cases NK Mollanazar, CC Qiu, JL Aldrich, E Tedaldi, R Valdes‐Rodriguez, ... British Journal of Dermatology 181 (6), 1311-1312, 2019 | 26 | 2019 |
| Cutaneous T-cell lymphoma and concomitant atopic dermatitis responding to dupilumab NK Mollanazar, KT Savage, BT Pousti, N Jariwala, C Del Guzzo, P Haun, ... Cutis 106 (3), 131-132, 2020 | 19 | 2020 |
| Validation and banding of the ItchyQuant: a self-report itch severity scale CG Haydek, E Love, NK Mollanazar, RV Rodriguez, H Lee, G Yosipovitch, ... Journal of Investigative Dermatology 137 (1), 57-61, 2017 | 19 | 2017 |
| Cholinergic induction of perspiration attenuates nonhistaminergic pruritus in the skin of patients with atopic dermatitis and healthy controls LA Nattkemper, HG Lee, R Valdes‐Rodriguez, NK Mollanazar, ... British Journal of Dermatology 173 (1), 282-284, 2015 | 16 | 2015 |
| Acute generalized exanthematous pustulosis due to terbinafine CL Ross, A Shevchenko, NK Mollanazar, S Hsu, K Motaparthi Dermatologic Therapy 31 (4), e12617, 2018 | 13 | 2018 |
| Lichen‐planus‐pemphigoides‐like reaction to PD‐1 checkpoint blockade M Wat, NK Mollanazar, CT Ellebrecht, A Forrestel, R Elenitsas, EY Chu Journal of Cutaneous Pathology 49 (11), 978-987, 2022 | 10 | 2022 |
| Gabapentinoids for pruritus in older adults: a narrative review SA Sreekantaswamy, N Mollanazar, DC Butler Dermatology and Therapy 11, 669-679, 2021 | 10 | 2021 |
| Dupilumab for the treatment of lichen planus BT Pousti, A Jin, L Sklovar, KT Savage, LL Zhai, NK Mollanazar, ... Cutis 107 (4), E8-E10, 2021 | 8 | 2021 |
